SCHEMBL4285922

SCHEMBL4285922

CC(C)COc1ccc(Cc2ccc(OCC(C)C)c(CCC(=O)O)c2)c(OCC(C)C)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FOS P01100 2/20 0.64
JUN P05412 2/20 0.64
PPARG P37231 7/20 0.47
PPARD Q03181 7/20 0.47
PPARA Q07869 6/20 0.47
TP53 P04637 1/20 0.43
MDM2 Q00987 1/20 0.43
FFAR1 O14842 3/20 0.43
BCL2L1 Q07817 2/20 0.43
MCL1 Q07820 2/20 0.43
FFAR4 Q5NUL3 1/20 0.40
ALDH1A1 P00352 1/20 0.40
HIF1A Q16665 1/20 0.40
POLB P06746 1/20 0.40
BCL2L11 O43521 1/20 0.39
BAK1 Q16611 1/20 0.39
PTGER1 P34995 1/20 0.39
PTGER4 P35408 1/20 0.39
PTGER3 P43115 1/20 0.39
PTGER2 P43116 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4279601 0.91 FOS (0.61) FOSJUNPPARGPPARDPPARA
SCHEMBL4284099 0.88 FOS (0.48) FOSJUNPPARGPPARDPPARA
SCHEMBL4276620 0.82 JUN (0.81) FOSJUNPPARGPPARDPPARA
SCHEMBL4282700 0.80 JUN (0.81) FOSJUNPPARGPPARDPPARA
SCHEMBL27908941 0.78 FOS (0.56) FOSJUNALDH1A1HIF1APTGER1
SCHEMBL4285091 0.78 FOS (0.61) FOSJUNPPARGPPARDPPARA
SCHEMBL1527292 0.78 FOS (1.00) FOSJUNPPARGPPARDPPARA
SCHEMBL31191805 0.78 FOS (1.00) FOSJUNPPARGPPARDPPARA
SCHEMBL4283756 0.77 FOS (0.60) FOSJUNPPARGPPARDPPARA
SCHEMBL4279563 0.77 JUN (0.76) FOSJUNPPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090118169-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL USE THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-05-07 US disclosed
US-7314888-B1 Compounds and medicinal use thereof TOYAMA CHEMICAL CO., LTD. (JP) 2008-01-01 US disclosed
CN-1325376-A Novel compound and medical use thereof TOYAMA CHEMICAL CO LTD (JP) 2001-12-05 CN disclosed
EP-1127869-A1 NOVEL COMPOUNDS AND MEDICINAL USE THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2001-08-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090118169-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL USE THEREOF SP1, AP1G1, AP1M1 FOS 63/4885JUN 20/4885PPARG 1497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.